These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 37275856)

  • 1. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors.
    Dai Z; Liu WC; Chen XY; Wang X; Li JL; Zhang X
    Front Immunol; 2023; 14():1178662. PubMed ID: 37275856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylation at a conserved cysteine residue facilitates gasdermin D-mediated pyroptosis and cytokine release.
    Liu Z; Li S; Wang C; Vidmar KJ; Bracey S; Li L; Willard B; Miyagi M; Lan T; Dickinson BC; Osme A; Pizarro TT; Xiao TS
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2400883121. PubMed ID: 38980908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into Gasdermin D pore formation.
    Kappelhoff S; Margheritis EG; Cosentino K
    Biochem Soc Trans; 2024 Apr; 52(2):681-692. PubMed ID: 38497302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gasdermin D in inflammatory diseases: from mechanism to therapeutics.
    Cheng CK; Yi M; Wang L; Huang Y
    Front Immunol; 2024; 15():1456244. PubMed ID: 39253076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways.
    Dubyak GR; Miller BA; Pearlman E
    Immunol Rev; 2023 Mar; 314(1):229-249. PubMed ID: 36656082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroptosis inhibiting nanobodies block Gasdermin D pore formation.
    Kopp A; Hagelueken G; Jamitzky I; Moecking J; Schiffelers LDJ; Schmidt FI; Geyer M
    Nat Commun; 2023 Dec; 14(1):7923. PubMed ID: 38040708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Gasdermin-D-Mediated Pyroptosis in Organ Injury and Its Therapeutic Implications.
    Mulla J; Katti R; Scott MJ
    Organogenesis; 2023 Dec; 19(1):2177484. PubMed ID: 36967609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications.
    Liu Z; Chen Y; Mei Y; Yan M; Liang H
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairing Gasdermin D-mediated pyroptosis is protective against retinal degeneration.
    Sekar R; Wooff Y; Cioanca AV; Kurera M; Ngo C; Man SM; Natoli R
    J Neuroinflammation; 2023 Oct; 20(1):239. PubMed ID: 37864169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Gasdermin Pores.
    Wang K; Ding J; Shao F
    Methods Mol Biol; 2023; 2696():149-167. PubMed ID: 37578722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway.
    Evavold CL; Hafner-Bratkovič I; Devant P; D'Andrea JM; Ngwa EM; Boršić E; Doench JG; LaFleur MW; Sharpe AH; Thiagarajah JR; Kagan JC
    Cell; 2021 Aug; 184(17):4495-4511.e19. PubMed ID: 34289345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gasdermin D-Mediated Pyroptosis Promotes the Development of Atherosclerosis.
    Huang B; Zou Z; Li Y; Chen H; Lai K; Yuan Y; Xu Y
    Lab Invest; 2024 Apr; 104(4):100337. PubMed ID: 38266921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of gasdermin D pore-forming activity.
    Devant P; Kagan JC
    Nat Immunol; 2023 Jul; 24(7):1064-1075. PubMed ID: 37277654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling.
    Li Y; Jiang Q
    Front Immunol; 2023; 14():1128358. PubMed ID: 37090724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Lytic and Non-Lytic Functions of Gasdermin Pores.
    Rühl S; Broz P
    J Mol Biol; 2022 Feb; 434(4):167246. PubMed ID: 34537232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor.
    Yang J; Liu Z; Wang C; Yang R; Rathkey JK; Pinkard OW; Shi W; Chen Y; Dubyak GR; Abbott DW; Xiao TS
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6792-6797. PubMed ID: 29891674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroptosis and the cellular consequences of gasdermin pores.
    Huston HC; Anderson MJ; Fink SL
    Semin Immunol; 2023 Sep; 69():101803. PubMed ID: 37437353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gasdermin D triggers cardiolipin-driven mitochondrial damage and pyroptosis.
    Cai Q; Shubhra QTH
    Trends Immunol; 2024 Feb; 45(2):75-77. PubMed ID: 38242759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy.
    Li LR; Chen L; Sun ZJ
    Life Sci; 2024 Oct; 354():122951. PubMed ID: 39127315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.